Fiscal first quarter sales ending December 31, 2014, for Brooks Automation Life Science Systems (LSS) grew 36.8%, 7.3% excluding the acquisition of FluidX (see IBO 10/15/14), to $16.7 million (see page 12) to account for 14% of company sales. Product revenue grew 56.9%, 12.7% excluding the acquisition, to account for 77% of LSS revenue. LSS […]
As a result of Russia’s economic crisis and the devaluation of the ruble, the country will decrease its funding for national universities this year by at least 10%. The government expects the universities to make up the difference, from $4.2 billion last year to $3.8 billion this year, by acquiring private funds and investments, commercializing […]
“The Nature Index 2015” for the Asia-Pacific region was released in March. The Index tracks articles published in selected science journals chosen by a group of independent researchers, and is used to assess the impact and productivity of countries. A country’s weighted fractional count (WFC) is a measure of articles with authors from a country, […]
As of this month, the Japan Agency for Medical Research and Development will have been established to improve medical care, and help develop drugs and medical equipment in the country. It will distribute the ¥140 billion ($1.16 billion) research budget of several ministries across nine fields that the Japanese government considers important. The areas are […]
A survey conducted by Chemical & Engineering News (C&EN) of European and US chemical firms found a wide range of plans for R&D and capital spending for 2015 as a result of economic conditions in the US, Europe and China. The eight companies providing estimates of R&D spending anticipated expenditures totaling $3,574 million, a gain […]
In March, DeCode Genetics published four papers in Nature Genetics on its study sequencing the genomes of 2,636 Icelanders. The research detected rare mutations protecting individuals against disease, and the company reported finding more than 20 million genetic variants. Some of these variants were associated with increased risks for conditions, including a gene associated with […]
The US FDA is experiencing insufficient funding to carry out the steps required by the Food Safety Modernization Act (FSMA) of 2010 (see IBO 12/31/10). According to the Congressional Budget Office, the FDA would have needed $580 million to do this from 2011 to 2015. However, less than half of the amount has been appropriated. […]
Fourth quarter 2014 IBO Lab Equipment/Consumables Sales Index revenues grew 4.6%, 6.3% excluding currency, to $4,679 million. Growth was driven by strong results for Thermo Fisher Scientific Laboratory Products and Services (LPS). Index adjusted operating profit improved only 0.3% to $811 million. Operating margin declined 70 basis points to 15.7% of sales due to divestments, […]
Washington, DC 4/6/15; Morgantown, VA 4/7/15; Bundorra, Canada 4/7/15—Protea Biosciences, a supplier of bioanalytical solutions, has agreed to acquire vivoPharm for $11.1 million in cash and stock. vivoPharm provides pharmacology, toxicology and bioanalytical research services, including oncology models. “vivoPharm has developed a large standard-of-care reference database. We believe that this critical asset, together with Protea’s […]
Washington, DC 4/6/15—OpGen has disclosed in an SEC filing for its IPO (see IBO 3/15/15) that it plans to offer 3,750,000 shares of common stock at a price of $8–$10 per share. Assuming a price of $9 per share, the company expects to raise $30.5 million, or $35 million if underwriters exercise their option.
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
